Healthy Living

Dr Ross Walker speaks with Dr Jeffery Tho from Sleepwise Clinics about oral devices for the treatment of sleep apnea as an alternative to CPAP machines. 

See omnystudio.com/listener for privacy information.

Dr. Ross Walker speaks with Ken Griffin, CEO of AUSactive, about how exercise is also an essential part of the prescription.

See omnystudio.com/listener for privacy information.

Listen to Healthy Living with Dr Ross Walker and Adam Buncher, the full show podcast.

See omnystudio.com/listener for privacy information.

Dr Ross Walker speaks with Dr Tanveer Ahmed about  mother navigating the emotional rollercoaster of a difficult birth using skin-to-skin contact often called Kangaroo Mother Care.

See omnystudio.com/listener for privacy information.

Listen to Healthy Living with Dr Ross Walker and Adam Buncher, the full show podcast.

See omnystudio.com/listener for privacy information.

Dr. Ross Walker and stem cell expert Dr. Ben Herbert explore the groundbreaking shift in Type 1 diabetes treatment: moving from lifelong insulin injections to actually replacing the destroyed insulin-producing cells. 

See omnystudio.com/listener for privacy information.

We are joined by Bryce Perron from CPAP Direct discussing the impact of Sleep Apnea. To find out more about CPAP Direct go to https://cpap.com.au/

See omnystudio.com/listener for privacy information.

A groundbreaking study published in Molecular Cancer Therapeutics brings new hope to the fight against pediatric cancer. Led by the Children’s Cancer Institute, in collaboration with UNSW Sydney, Monash University, and Queensland Children’s Hospital, researchers have discovered that a specific class of targeted cancer drugs could benefit a much broader group of children than previously recognised.

Dr Ross Walker speaks with Associate Professor Emmy Fleuren - Team Leader at Children's Cancer Institute 

See omnystudio.com/listener for privacy information.

Dr Ross Walker talk to Dr Tanveer Ahmed about the latest ADHD research. 

See omnystudio.com/listener for privacy information.

Dr Ross Walker speaks with Professor John Wentworth, Endocrinologist and Senior Clinical Research Fellow at St Vincent's Institute of Medical Research. We discuss the TGA’s historic registration of Tzield, the very first non-insulin medicine designed to delay the onset of clinical Type 1 diabetes.

To find out more go to https://breakthrought1d.org.au/news/tzield-approved-in-australia/ 

See omnystudio.com/listener for privacy information.